Alternatives to Joint Replacement Surgery in Inglewood, CA

What I’d check before adding non surgical alternatives to joint replacement here

Adult obesity in Inglewood is 32.6% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 14.5% of adults in Inglewood have diagnosed diabetes — 2.5 points above the U.S. 12% figure. California is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for non surgical alternatives to joint replacement, not a walk-in clinic.

Cash PRP and Medicare CTPs in the same hallway

• Adult arthritis here is 21% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 14.4% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in California.
• California is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).
• HCT/P 361 products must be minimally manipulated and used homologously. California medical boards and the FTC have both acted against regenerative advertising that implies stem-cell cures. Inventory choice and website copy have to match.

Payer geography for Inglewood, CA

JE reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Inglewood is 14.5% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic